US09075V1026
US09075V1026
BioNTech SE
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 24.36B EUR | 23.37B EUR | 22.48B EUR | 23.93B EUR |
Enterprise Value | 9.98B EUR | 13.95B EUR | 12.84B EUR | 16.52B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -17.68x | -- | -- | -- |
Price to Sales | 9.19x | 8.82x | 8.01x | 8.9x |
Price to Book | 1.22x | 1.32x | 1.2x | 1.24x |
EV/Revenue | 3.77x | 5.26x | 4.58x | 6.15x |
EV/EBITDA | -7.23x | -- | -- | 34.14x |
Price to FCF (P/FCF) | -- | 52.56x | 37.1x | 21.64x |
EV/FCF | -- | 31.37x | 21.19x | 14.94x |
FCF Yield | -1.02% | 1.9% | 2.7% | 4.62% |